의료진 소개
예약 안내
김태은
[
임상약리학과
]
신약개발 임상시험, 적정약물요법, 약동학/약력학 분석
고맙습니다
예약문의
1588-1533
1588-1533
외래진료 외래진료
특수클리닉 특수클리닉
진료일정
04
| 날짜 |
|---|
| 오전 |
| 오후 |
논문
논문
- Kim TE, Kim HJ, Ki HK, Kim SH. The Impact of Metabolic Syndrome on Heart Failure in Young Korean Population: A Nationwide Study. Metabolites. 2024 Sep;14(9):485.
- Kim BS, Kim HJ, Kim TE, Kim SH. Different Impact of Metabolic Syndrome on the Risk of Incidence of the Peripheral Artery Disease and the Venous Thromboembolism: A Nationwide Longitudinal Cohort Study in South Korea. Reviews in Cardiovascular Medicine. 2023 Apr;24(4):113.
- Kim TE. Systemic exposure to propranolol in patients with chronic liver disease and its correlation with portal blood flow. Frontiers in Medicine. 2022 Sep;9:973606.
- Seo JD, Kim H, Kim TE, Yun YM. Pharmacokinetics and Genetic Factors of Atorvastatin in Healthy Korean Subjects. Frontiers in Genetics. 2022 May 19;13:836970.
- Kim TE. Clinical characteristics and outcome of coronavirus disease 2019 infection in patients with solid organ transplants: A systematic review and meta-analysis. Journal of Infection and Public Health. 2022 Mar;15(3):365-72.
- Kim TE. Cardiac biomarkers and COVID-19: A systematic review and meta-analysis. Journal of Infection and Public Health. 2021 Sep;14(9):1191-7.
- Kim TE. High-Performance Liquid Chromatography Coupled with High-Resolution Mass Spectrometry (UHPL-CHRMS) for the Detection of Metformin in Human Plasma. Molecules. 2020 Oct 11;25(20):4625.
- Kim TE, Yoo KH. Clinical Role of the Chronic Obstructive Pulmonary Disease Assessment Test in Prediction of the Response to Treatment for Exacerbations. Journal of Korean Medical Science. 2020 Jan 13;35(2):e10.
- Choi HS [et al.]. Validation of Previous Spirometric Reference Equations and New Equations. Journal of Korean Medical Science. 2019 Dec 9;34(47):e304.
- Jeong HC, Kim TE, Shin KH. Quantification of apixaban in human plasma using ultra performance liquid chromatography coupled with tandem mass spectrometry. Translational and Clinical Pharmacology. 2019 Mar;27(1):33-41.
- Kim TE. Association of TNF-alpha G-308A gene polymorphism with depression: a meta-analysis. Neuropsychiatric Disease and Treatment. 2017 Oct 20;13:2661-8.
- Kim TE, Kim JY. The Effect of Genetic Polymorphisms in SLCO2B1 on the Lipid-lowering Efficacy of Rosuvastatin in Healthy Adults with Elevated Low-density Lipoprotein. Basic & Clinical Pharmacology & Toxicology. 2017 Sep;121(3):195-201.
- Kim TE. Effect of epigallocatechin-3-gallate, major ingredient of green tea, on the pharmacokinetics of rosuvastatin in healthy volunteers. Drug Design, Development and Therapy. 2017 May 9;11:1409-16.
- Kim TE, Kim HJ, Joo EY, Seo DW, Lee SY, Hong SB. Effects of comedication on lamotrigine clearance in Korean epilepsy patients. Clin Chim Acta. 2015 Jan1;438:269-73 .
- Kim TE, Lee H, Lim KS, Lee S, Yoon SH, Park KM, Han H, Shin SG, Jang IJ, Yu KS, Cho JY. Effects of HM30181, a P-glycoprotein inhibitor, on the pharmacokinetics and pharmacodynamics of loperamide in healthy volunteers. Br J Clin Pharmacol. 2014 Sep;78(3):556-64 .
- Kim TE, Kim JR, Jung JA, Kim MJ, Lee SY, Ko JW, Jung WT, Choi YW, Lee HJ, Kim SH, Huh W. Pharmacokinetics of a new once-daily controlled-release sarpogrelate hydrochloride compared with immediate-release formulation and the effect of food. J Clin Pharm Ther. 2014 Apr;39(2):192-5 .
- Kim TE, Kim JR, Jung JA, Kim SR, Lee JW, Jun H, Lee SY, Huh W, Ko J. Comparison of pharmacokinetics between sarpogrelate hydrochloride immediate-release formulation and controlled-release formulation. IntJClinPharmacolTher. 2013Feb;51(2):114-9 .
- Kim TE, Lim KS, Park MK, Yoon SH, Cho JY, Shin SG, Jang IJ, Yu KS. Evaluation of the pharmacokinetics, food effect, pharmacodynamics, and tolerability of DA-1229, a dipeptidyl peptidase IV inhibitor, in healthy volunteers: first-in-human study. ClinTher. 2012Sep;34(9):1986-98 .
- Kim TE, Kim KP, Shin D, Chung YJ, Price J, Mistry P, Jang IJ, Yu KS. Assessment of the analgesic effect of remifentanil using three pain models in healthy Korean volunteers: a randomized, controlled study. BasicClinPharmacolToxicol. 2012Jun;110(6):518-23 .
- Kim TE, Gu N, Yoon SH, Cho JY, Park KM, Shin SG, Jang IJ, Yu KS. Tolerability and pharmacokinetics of a new P-glycoprotein inhibitor, HM30181, in healthy Korean male volunteers: single- and multiple-dose randomized, placebo-controlled studies. ClinTher. 2012Feb;34(2):482-94 .
- Kim TE, Kim KP, Kim BH, Shin SG, Jang IJ, Yu KS. Pharmacokinetic and pharmacodynamic comparison of two recombinant human erythropoietin formulations after single subcutaneous administration: an open-label, sequence-randomized, two-treatment crossover study in healthy Korean male volunteers. Clin Ther. 2010 Oct;32(11):1968-76 .
- Kim TE, Kim BH, Kim JW, Kim KP, Yi S, Shin HS, Lee YO, Lee KH, Shin SG, Jang IJ, Yu KS. Comparison of the pharmacokinetics of ticlopidine between coadministration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/ ginkgo extract 80 mg, and concomitant administration of ticlopidine 250 mg and ginkgo extract 80 mg tablets: an open-label, two-treatment, single-dose, randomized-sequence, crossover study in healthy Korean male volunteers. Clin Ther. 2009 Oct;31(10):2249-57 .
- Kim TE, Kim BH, Kim JR, Lim KS, Hong JH, Kim KP, Kim HS, Shin SG, Jang IJ, Yu KS. Effect of food on the pharmacokinetics of the oral phosphodiesterase 5 inhibitor udenafil for the treatment of erectile dysfunction. Br J Clin Pharmacol. 2009 Jul;68(1):43-6.